Genmab A/S 6-K Filing
Ticker: GNMSF · Form: 6-K · Filed: Nov 12, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 12, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Genmab A/S (ticker: GNMSF) to the SEC on Nov 12, 2025.
How long is this filing?
Genmab A/S's 6-K filing is 1 pages with approximately 214 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 214 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-11-12 16:28:38
Filing Documents
- d768286d6k.htm (6-K) — 10KB
- d768286dex991.htm (EX-99.1) — 13KB
- d768286dex992.htm (EX-99.2) — 11KB
- d768286dex993.htm (EX-99.3) — 510KB
- d768286dex994.htm (EX-99.4) — 437KB
- d768286dex995.htm (EX-99.5) — 1154KB
- g768286dsp4.jpg (GRAPHIC) — 5KB
- g768286g02a01.jpg (GRAPHIC) — 23KB
- g768286g02a02.jpg (GRAPHIC) — 27KB
- g768286g02a03.jpg (GRAPHIC) — 22KB
- g768286g02a04.jpg (GRAPHIC) — 24KB
- g768286g02a05.jpg (GRAPHIC) — 24KB
- g768286g02a06.jpg (GRAPHIC) — 23KB
- g768286g02a07.jpg (GRAPHIC) — 24KB
- g768286g02a08.jpg (GRAPHIC) — 25KB
- g768286g02a09.jpg (GRAPHIC) — 24KB
- g768286g02a10.jpg (GRAPHIC) — 28KB
- g768286g02a11.jpg (GRAPHIC) — 21KB
- g768286g14k14.jpg (GRAPHIC) — 780KB
- g768286g19k19.jpg (GRAPHIC) — 125KB
- g768286g46o62.jpg (GRAPHIC) — 4KB
- g768286g60k60.jpg (GRAPHIC) — 27KB
- g768286g64k64.jpg (GRAPHIC) — 25KB
- g768286g65a20.jpg (GRAPHIC) — 98KB
- g768286g65a60.jpg (GRAPHIC) — 113KB
- 0001193125-25-277733.txt ( ) — 4030KB
From the Filing
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2025 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Announcement, dated November 10, 2025. 99.2 Announcement, dated November 10, 2025. 99.3 Excerpts from Preliminary Offering Memorandum. 99.4 Unaudited Pro Forma Condensed Combined Financial Information from the Preliminary Offering Memorandum. 99.5 Audited consolidated financial statements as of and for the years ended December 31, 2024, 2023 and 2022, originally prepared in Danish Kroner and retranslated into United States Dollars for all periods presented. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: NOVEMBER 12, 2025